201![WHOPAR [FDA] Aurobindo Abacavir 300 mg tabs WHOPAR [FDA] Aurobindo Abacavir 300 mg tabs](https://www.pdfsearch.io/img/17763f6e1f516f5dca0dad33c33f1325.jpg) | Add to Reading ListSource URL: apps.who.intLanguage: English - Date: 2009-10-16 03:51:10
|
---|
202![FDA Tentative Approval November 8, 2005 Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma, Ltd. 1 FDA Tentative Approval November 8, 2005 Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma, Ltd. 1](https://www.pdfsearch.io/img/950b73b314d54b9e0cc2774fa0f03e92.jpg) | Add to Reading ListSource URL: apps.who.intLanguage: English - Date: 2009-12-08 04:25:30
|
---|
203![This list contains the drug products available through Navitus SpecialtyRx Program This list contains the drug products available through Navitus SpecialtyRx Program](https://www.pdfsearch.io/img/b5b3817401d62f7113c5330933cf8bde.jpg) | Add to Reading ListSource URL: www.deancare.comLanguage: English - Date: 2013-12-26 16:12:00
|
---|
204![Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting[removed]AASLD) - Achillion Achieves 100% SVR12 in Eight-Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting[removed]AASLD) - Achillion Achieves 100% SVR12 in Eight-Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and](https://www.pdfsearch.io/img/db8887a5cffe0f4b543e1a167fdc9d26.jpg) | Add to Reading ListSource URL: www.hepcassoc.orgLanguage: English - Date: 2014-11-10 11:48:35
|
---|
205![Popular HCV Drug Combo Wins FDA Backing Nov 6, 2014 By Michael Smith, North American Correspondent, MedPage Today A drug combination widely used off-label to treat hepatitis C (HCV) has been given the nod by the FDA. The Popular HCV Drug Combo Wins FDA Backing Nov 6, 2014 By Michael Smith, North American Correspondent, MedPage Today A drug combination widely used off-label to treat hepatitis C (HCV) has been given the nod by the FDA. The](https://www.pdfsearch.io/img/c5de8b6d52d70dc965f4e505a37fdfd8.jpg) | Add to Reading ListSource URL: www.hepcassoc.orgLanguage: English - Date: 2014-11-07 08:54:14
|
---|
206![New drug could eliminate hepatitis C in 15 years The Pharmaceutical Journal, 10 SEP 2014, By Janna Lawrence Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination wi New drug could eliminate hepatitis C in 15 years The Pharmaceutical Journal, 10 SEP 2014, By Janna Lawrence Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination wi](https://www.pdfsearch.io/img/4524c95b2953feb570e4f3b05f42020f.jpg) | Add to Reading ListSource URL: www.hepcassoc.orgLanguage: English - Date: 2014-09-15 11:42:23
|
---|
207![Bristol-Myers pulls U.S. marketing application for hepatitis C treatment Oct 7 (Reuters) - Bristol-Myers Squibb said it withdrew its U.S. marketing application for a drug combination to treat hepatitis C. The drugmaker w Bristol-Myers pulls U.S. marketing application for hepatitis C treatment Oct 7 (Reuters) - Bristol-Myers Squibb said it withdrew its U.S. marketing application for a drug combination to treat hepatitis C. The drugmaker w](https://www.pdfsearch.io/img/845548c149edf565c1beae591da632d8.jpg) | Add to Reading ListSource URL: www.hepcassoc.orgLanguage: English - Date: 2014-10-08 16:23:27
|
---|
208![FOURTH INVITATION FOR EXPRESSION OF INTEREST (EOI) (Artemisinin based Antimalarial Products) May 2005 In the context of facilitating access to Artemisinin based combination antimalarial drug products, Roll Back Malaria ( FOURTH INVITATION FOR EXPRESSION OF INTEREST (EOI) (Artemisinin based Antimalarial Products) May 2005 In the context of facilitating access to Artemisinin based combination antimalarial drug products, Roll Back Malaria (](https://www.pdfsearch.io/img/90217d0c6d443e52c23088af76065edf.jpg) | Add to Reading ListSource URL: apps.who.intLanguage: English - Date: 2007-07-04 05:34:04
|
---|
209![HIV/AIDS Expression of Interest EOI HIV/AIDS Expression of Interest EOI](https://www.pdfsearch.io/img/ef98516769c831c5bb7e942f08623672.jpg) | Add to Reading ListSource URL: apps.who.intLanguage: English - Date: 2008-05-28 07:41:36
|
---|
210![Kansas State Group Health Insurance Program Member Preferred Drug List 2015 Kansas State Group Health Insurance Program Member Preferred Drug List 2015](https://www.pdfsearch.io/img/f234a58334d5350de11e8fb82daa9bb1.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2014-12-05 08:16:34
|
---|